Drug Enforcement D-916-2013

cGMP Deviations; during the production process, CLENZIderm M.D. Daily Foam Cleanser was filled into some bottles labeled as CLENZIderm M.D. Pore Therapy

Status

Terminated

Classification

Class II

Report Date

August 28, 2013

Termination Date

April 15, 2014

Product Information

Product description
CLENZIderm M.D. Acne Therapeutic System Normal to Oily Skin kit, Distributed by OMP, Inc., Long Beach, CA 90806, Kit is comprised of: Daily Care Foaming Cleanser (Salicylic Acid 2%) NDC 62032-111; Pore Therapy (Salicylic Acid 2%) NDC 62032-110 and Therapeutic Lotion (Benzoyl Peroxide 5%) NDC 562032-113). Product under recall is the Pore Therapy (Salicylic Acid 2%), NDC 62032-110.
Product quantity
2491 Kits; Expanded 8/29/2013 to include an additional 907 units.
Reason for recall
cGMP Deviations; during the production process, CLENZIderm M.D. Daily Foam Cleanser was filled into some bottles labeled as CLENZIderm M.D. Pore Therapy
Recall initiation reason
Initial firm notification
Telephone
Distribution pattern
Nationwide, Great Britain, Mexico, Russia and The Ukraine.

Location & Firm

Recalling firm
Medicis Pharmaceutical Corp
Address
7720 N Dobson Rd, N/A

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date

Codes & Dates

Recall number
D-916-2013
Event ID
65559
Recall initiation date
May 1, 2013
Center classification date
August 22, 2013
Code info
Lot #11L1074, NDC 62032-110; Expanded 8/29/2013 to include Lot 11J1075, NDC 62032-511, Exp. 10/14.
More code info